Oncotarget

Research Papers:

MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma

Ling Chen, Guangming Kong, Chuantao Zhang, Hongyan Dong, Cuicui Yang, Guanhua Song, Chengye Guo, Lin Wang and Hongsheng Yu _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:20041-20053. https://doi.org/10.18632/oncotarget.7884

Metrics: PDF 2371 views  |   HTML 2242 views  |   ?  


Abstract

Ling Chen1,2, Guangming Kong3, Chuantao Zhang1, Hongyan Dong4, Cuicui Yang4, Guanhua Song5, Chengye Guo2, Lin Wang6, Hongsheng Yu1

1Department of Oncology, Affiliated Hospital of Qingdao University, Qingdao, China

2Department of Oncology, Qingdao Municipal Hospital, Qingdao, China

3Emergency Department, Qingdao Municipal Hospital, Qingdao, China

4Department of Pathology, Linyi People’s Hospital, Linyi, China

5Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan, China

6Research Center for Medicinal Biotechnology, Key Laboratory for Rare and Uncommon Diseases of Shandong Province, Shandong Academy of Medical Sciences, Jinan, China

Correspondence to:

Hongsheng Yu, e-mail: [email protected]

Lin Wang, e-mail: [email protected]

Keywords: lung adenocarcinoma, miR-432, E2F3, AXL

Received: August 05, 2015     Accepted: January 31, 2016     Published: March 03, 2016

ABSTRACT

Abnormal proliferation and drug resistance are the hallmarks of lung adenocarcinoma (LAD). Dispite the advances in diagnosis and therapy, the 5-year survival remains low. Increasing studies regarding its pathological mechanism have been focused on microRNA (miRNA) due to its nodal regulatory properties. This study aims to characterize the expression of miR-432 in LAD and investigate its effects on the proliferation and sensitivity of lung cancer cells to cisplatin. Here, we report that downregulation of miR-432 in LAD tissues was correlated with a higher clinical stage (p = 0.03) and poor prognosis (p = 0.036). Additionally, miR-432 expression was negative correlated with high Ki67 labeling index (p = 0.016) in our cohorts. Functionally, over-expression of miR-432 inhibits cell proliferation through arresting cell cycle and sensitizes tumor cells to cisplatin. Mechanistically, miR-432 functions by directly targeting E2F3 and AXL, and they, in turn, mediate the regulation of miR-432 towards cell proliferation and cisplatin sensitivity. Importantly, miR-432 levels are negatively correlated with the levels of E2F3 and AXL in human LAD tissues. These results demonstrated that miR-432 functions as a tumor-suppressive miRNA and may represent a prognostic parameter and therapeutic target for LAD.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7884